Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation

RATIONALE: A high incidence of GLA IVS4+919 G>A mutation in patients with Fabry disease of the later-onset cardiac phenotype, has been reported in Taiwan. However, suitable biomarkers or potential therapeutic surrogates for Fabry cardiomyopathy (FC) in such patients under enzyme replacement treat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Chien, Yueh, Chien, Chian-Shiu, Chiang, Huai-Chih, Huang, Wei-Lin, Chou, Shih-Jie, Chang, Wei-Chao, Chang, Yuh-Lih, Leu, Hsin-Bang, Chen, Kuan-Hsuan, Wang, Kang-Ling, Lai, Ying-Hsiu, Liu, Yung-Yang, Lu, Kai-Hsi, Li, Hsin-Yang, Sung, Yen-Jen, Jong, Yuh-Jyh, Chen, Yann-Jang, Chen, Chung-Hsuan, Yu, Wen-Chung
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349979/
https://ncbi.nlm.nih.gov/pubmed/27888626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13552
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados